Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

GRANDE PHARMACIE : revenue, balance sheet and financial ratios

GRANDE PHARMACIE is a French company founded 23 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-AMAND-MONTROND (18200), this company of category PME shows in 2023 a revenue of 1.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - GRANDE PHARMACIE (SIREN 443722731)
Indicador 2025 2023 2022
Ingresos N/C 1 528 360 € N/C
Resultado neto 597 € 175 € 69 €
EBITDA N/C 9 957 € N/C
Margen neto N/C 0.0% N/C

Ingresos y cuenta de resultados

In 2025, GRANDE PHARMACIE generates positive net income of 597 €. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2025: 69 € -> 597 €.

Resultado neto (2025) ?
Resultado neto
Definición
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Fórmula
Resultado corriente + Resultado excepcional - Impuesto sobre beneficios

597 €

Chargement du compte de résultat...

Évolution graphique

Mostrar :

Activo

Chargement des données...

Pasivo

Chargement des données...

Ratios de solvencia y endeudamiento

The debt ratio (= Financial debt / Equity x 100) stands at 5%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 83%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Ratio de endeudamiento (2025) ?
Ratio de endeudamiento
Definición
Mide la proporción de deuda respecto a los fondos propios.
Fórmula
(Deuda financiera / Fondos propios) x 100
Interpretación
< 50% : Faible
50-100% : Moderado
> 100% : Alto

5.263%

Autonomía financiera (2025) ?
Autonomía financiera
Definición
Porcentaje de fondos propios en la financiación total.
Fórmula
(Fondos propios / Total balance) x 100
Interpretación
> 30% : Buena autonomía
20-30% : Media
< 20% : Faible

82.557%

Ratio de obsolescencia (2025) ?
Ratio de obsolescencia
Definición
Mide el grado de desgaste del inmovilizado material.
Fórmula
Amortización acumulada / Inmovilizado bruto x 100
Interpretación
< 50% : Activos recientes
50-70% : Desgaste normal
> 70% : Activos envejecidos

8.8%

Evolución de indicadores de solvencia
GRANDE PHARMACIE

Positionnement sectoriel

Debt ratio
5.26 2025
2022
2023
2025
Q1: 13.7
Méd: 49.79
Q3: 129.09
Excellent

In 2025, the debt ratio of GRANDE PHARMACIE (5.26) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
82.56% 2025
2022
2023
2025
Q1: 33.42%
Méd: 53.72%
Q3: 72.08%
Excellent +8 pts durante 3 años

In 2025, the financial autonomy of GRANDE PHARMACIE (82.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
5.43 years 2023
2023
Q1: 0.95 years
Méd: 3.59 years
Q3: 7.48 years
Average

In 2023, the repayment capacity of GRANDE PHARMACIE (5.43) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Ratios de liquidez

The liquidity ratio (= Current assets / Current liabilities) stands at 148.27. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Ratio de liquidez (2025) ?
Ratio de liquidez
Definición
Capacidad para pagar las deudas a corto plazo con el activo circulante.
Fórmula
Activo circulante / Pasivo circulante
Interpretación
> 1.5 : Muy bueno
1-1.5 : Correcto
< 1 : Risque de liquidité

148.266

Evolución de indicadores de liquidez
GRANDE PHARMACIE

Positionnement sectoriel

Liquidity ratio
148.27 2025
2022
2023
2025
Q1: 131.03
Méd: 182.25
Q3: 258.64
Average

In 2025, the liquidity ratio of GRANDE PHARMACIE (148.27) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
3.73x 2023
2023
Q1: 0.38x
Méd: 2.71x
Q3: 6.47x
Good

In 2023, the interest coverage of GRANDE PHARMACIE (3.7x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Necesidad de fondo de rotación (NFR) y plazos de pago

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

NFR de explotación (2025) ?
NFR de explotación
Definición
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Fórmula
Stocks + Créances clients - Dettes fournisseurs
Interpretación
Negativo = tesorería liberada
Positivo = necesidad de financiación

0 €

Crédito clientes (2025) ?
Crédito clientes (días)
Definición
Plazo medio de cobro a clientes.
Fórmula
(Cuentas por cobrar / Ingresos con IVA) x 360
Interpretación
< 45j : Bueno
45-60j : Medio
> 60j : Largo

0 j

Crédito proveedores (2025) ?
Crédito proveedores (días)
Definición
Plazo medio de pago a proveedores.
Fórmula
(Cuentas por pagar / Compras con IVA) x 360
Interpretación
Cuanto más largo sea el plazo, mejor para la tesorería

0 j

Rotación de inventario (2025) ?
Rotación de inventario (días)
Definición
Duración media de almacenamiento de mercancías o materiales.
Fórmula
(Existencias / Coste de compra) x 360
Interpretación
Cuanto menor sea el ratio, más rápida es la rotación

0 j

Evolución del NFR y plazos
GRANDE PHARMACIE

Positionnement de GRANDE PHARMACIE dans son secteur

Comparación con el sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Estimación de valoración

Based on 277 transactions of similar company sales in 2025, the value of GRANDE PHARMACIE is estimated at 9 483 € (range 6 435€ - 14 880€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
6k€ 9k€ 14k€
9 483 € Range: 6 435€ - 14 880€
NAF 5 année 2025

Valuation method used

Net Income Multiple
597 € × 15.9x = 9 483 €
Range: 6 435€ - 14 881€

Only this financial indicator is available for this company.

Evolución de la valoración

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare GRANDE PHARMACIE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about GRANDE PHARMACIE

What is the revenue of GRANDE PHARMACIE ?

The revenue of GRANDE PHARMACIE in 2023 is 1.5 M€.

Is GRANDE PHARMACIE profitable?

Yes, GRANDE PHARMACIE generated a net profit of 597€ in 2025.

Where is the headquarters of GRANDE PHARMACIE ?

The headquarters of GRANDE PHARMACIE is located in SAINT-AMAND-MONTROND (18200), in the department Cher.

Where to find the tax return of GRANDE PHARMACIE ?

The tax return of GRANDE PHARMACIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GRANDE PHARMACIE operate?

GRANDE PHARMACIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.